Form 4 for GILD Gilead Sciences
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-10 · accession 0001127602-22-009207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-14 | 2022-03-10 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | $0.00 | +6,987 | 37.8K | +23% | $0 |
| D | 2022-03-14 | 2022-03-10 | GILD | Mercier Johanna | Chief Commercial Off | F - Tax | $57.92 | -3,221 | 34.5K | -9% | -$186.6K |
| DM | 2022-03-14 | 2022-03-10 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | — | -6,987 | 32.9K | -17% | — |
| DM | 2022-03-14 | 2022-03-10 | GILD | Mercier Johanna | Chief Commercial Off | A - Grant | $0.00 | +199.5K | 171.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | M | A | 3,025 | $0.00 | 33,803 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2022-03-10 | F | D | 3,221 | $57.92 | 34,544 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-10 | M | A | 3,962 | $0.00 | 37,765 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 4 | Derivative | Restricted Stock Unit | 2022-03-10 | M | D | 3,025 | — | 36,905 | D | — · — to — | 3,025 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2022-03-10 | A | A | 27,840 | — | 60,783 | D | — · — to — | 27,840 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 6 | Derivative | Non-qualified Stock Option (Right to Buy) | 2022-03-10 | A | A | 171,670 | $0.00 | 171,670 | D | $57.92 · — to 2032-03-10 | 171,670 Common Stock | (F4) The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 7 | Derivative | Restricted Stock Unit | 2022-03-10 | M | D | 3,962 | — | 32,943 | D | — · — to — | 3,962 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |